Work

The impact of EGFR subtype combined with TP53 co-mutation status on survival outcomes with front-line osimertinib in non-small cell lung cancer (NSCLC)

Year: 2026

Type: article

Study design: Observational Study

Source: Lung Cancer

DOI: 10.1016/j.lungcan.2026.109582

Authors: Hye Sung Kim, Li Zhang, J. Nicholas Bodor, Margie L. Clapper, Hossein Borghaei, Martin J. Edelman, Yunyun Zhou, Mitchell Cheung, Joseph Treat

Institutions: Temple University Hospital, Fox Chase Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Foundation for the National Institutes of Health, Flatiron Health, National Institutes of Health, Fox Chase Cancer Center, National Cancer Institute

Awards: G8669705299, Comprehensive Cancer Center Program at Fox Chase

OpenAlex ID: W7203471171

FWCI:

Cites: 8

Cited by:

Related to: 10